|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Octachloronaphthalene | CAS 2234-13-1 | ||
| C10Cl8 | RTECS QK0250000 | ||
|
Synonyms & Trade Names Halowax® 1051; 1,2,3,4,5,6,7,8-Octachloronaphthalene; Perchloronaphthalene |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: TWA 0.1 mg/m3 ST 0.3 mg/m3 [skin] | ||
| OSHA PEL†: TWA 0.1 mg/m3 [skin] | |||
| IDLH Unknown See: 2234131 | Conversion | ||
|
Physical Description Waxy, pale-yellow solid with an aromatic odor. |
|||
|
MW: 403.7 |
BP: 770°F |
MLT: 365°F |
Sol: Insoluble |
|
VP: <1 mmHg |
IP: ? |
|
Sp.Gr: 2.00 |
|
Fl.P: NA |
UEL: NA |
LEL: NA |
|
| Noncombustible Solid | |||
|
Incompatibilities & Reactivities Strong oxidizers |
|||
|
Measurement Methods NIOSH S97 (II-2) See: NMAM or OSHA Methods |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated/Daily Remove: When wet or contaminated Change: Daily |
First Aid (See procedures) Eye: Irrigate immediately Skin: Water flush immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Important additional information about respirator selection Respirator Recommendations NIOSH/OSHA Up to 1 mg/m3: (APF = 10) Any supplied-air respirator/(APF = 50) Any self-contained breathing apparatus with a full facepiece Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having a high-efficiency particulate filter/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Acne-form dermatitis; liver damage, jaundice | |
|
Target Organs
Skin, liver |
|
| See also: INTRODUCTION See ICSC CARD: 1059 See MEDICAL TESTS: 0169 |